The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Journal club: SURMOUNT-4 and continuation versus withdrawal

This is a generated summary. It shows the 5 most-liked posts from a topic of 37, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
MA
m.agyemanTL29 Mar 2026#5

Since SURMOUNT-4 and continuation versus withdrawal keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience will review it.

29 likes 5mo
BR
b.restrepoTL216 Mar 2026#9

Worth separating two things that post #7 runs together.

The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.

22 likes 4mo
HC
h.castellanosTL227 Mar 2026#16
b.restrepo, post #9: Worth separating two things that post #7 runs together. The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. Go to post

Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything that follows.

It is worth checking rather than assuming, which costs nothing.

29 likes in reply to #9 4mo
UC
unit_conversionTL3Regular3 Apr 2026#21

I had written a reply contradicting post #19 and deleted it. Here is what survived.

The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.

Reporting the observation and leaving the explanation open deliberately.

30 likes 4mo
OB
owen.bradyTL4 Moderator24 Apr 2026#37
unit_conversion, post #21: I had written a reply contradicting post #19 and deleted it. Here is what survived. The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. Reporting the observation and leaving the explanation open deliberately. Go to post

Marking my place. If it changes for me I will come back and say so.

24 likes in reply to #21 3mo

Read the full topic (37 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Journal club: SUSTAIN 6 and its retinopathy signal
On the subject in the title: Journal club: SUSTAIN 6 and its retinopathy signal Working notes rather than a conclusion. Reading SUSTAIN 6 ( N Engl J Med , 2016) for the population rather than the effect,…
LAMRZHOJI+110 122 46k 1d
Journal club: the retatrutide phase 2 obesity paper
Journal club: the retatrutide phase 2 obesity paper — setting out what I have, and where I think it stops being reliable. Collecting what is known about retatrutide phase 2 obesity paper in one place, because…
LFVDAERASV+7 11 33k 7mo
Journal club: what we got wrong in an earlier session
On the subject in the title: Journal club: what we got wrong in an earlier session Working notes rather than a conclusion. Bringing a claim rather than a paper, because the claim is the thing circulating. The…
NAFPALVSFT+114 125 2.5k 23h
Journal club: STEP 4 and what a withdrawal design can prove
On the subject in the title: Journal club: STEP 4 and what a withdrawal design can prove Working notes rather than a conclusion. Session topic: STEP 4 ( JAMA , 2021). Please read it before posting; the…
DJTVGHIO+61 65 2k 13mo
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset
Posting this under the heading it deserves: Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Everything below is what sits behind that. Posting a small dataset on SURMOUNT-4 and…
VMLADNWMD+58 64 17k 13mo

Related topics — sharing the tags journal club, number needed to treat, effect size

TopicParticipantsRepliesViewsActivity
Citing a preprint in a maintained document: our rule and its reasoning
On the subject in the title: Citing a preprint in a maintained document: our rule and its reasoning Working notes rather than a conclusion. A preprint question rather than a question about the finding in it.…
OVSLTN 2 467 4mo
Coming back to: A critique that turned out to be unfair, retracted by its author
A critique that turned out to be unfair, retracted by its author — setting out what I have, and where I think it stops being reliable. Reading back through what has been written here about critique, three…
IAQLJB 2 1.3k 14mo
Second pass at: Historical amylin analogues and what happened to them
Second pass at: Historical amylin analogues and what happened to them — setting out what I have, and where I think it stops being reliable. The question about Historical amylin analogues that I actually want…
ALCIPFBSV+15 19 22k 18mo
Follow-up: Retatrutide phase 2 in type 2 diabetes: the Lancet paper
Retatrutide phase 2 in type 2 diabetes: the Lancet paper Writing it up because I had to work it out twice and would rather nobody else did. A follow-up question about Retatrutide phase 2 in type that I did…
CDBNVSRAKF+1 5 31k 8mo
Follow-up: Is "synergy" the right word for the combination data?
Is "synergy" the right word for the combination data? I have a specific reason for asking rather than idle curiosity, and the context is below. Putting the numbers in the first post, because a question about…
CLBKSS 2 41k 14mo